Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Title:
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Author:
Hegewisch-Becker, Susanna Graeven, Ullrich Lerchenmüller, Christian A Killing, Birgitta Depenbusch, Reinhard Steffens, Claus-Christoph Al-Batran, Salah-Eddin Lange, Thoralf Dietrich, Georg Stoehlmacher, Jan Tannapfel, Andrea Reinacher-Schick, Anke Quidde, Julia Trarbach, Tanja Hinke, Axel Schmoll, Hans-Joachim Arnold, Dirk